-transparent.png){kind=logo}
BACKGROUND Anemia is common in patients with severe chronic liver disease, but its role in HBV-related decompensated cirrhosis (DeCi) is still unclear. We therefore aimed to assess the impact of anemia on prognosis in HBV-DeCi patients. METHODS One hundred thirty-three patients diagnosed with HBV-DeCi were retrospectively collected. RESULTS A total of 113 (85.0%) patients suffered from anemia in our cohort. The low hemoglobin (Hb) level group exhibited a significantly increased 28-day mortality rate compared with the high Hb group. Hb level was a predictor of 28-day mortality in HBV-DeCi patients. CONCLUSIONS Reduced Hb levels were associated with unfavorable prognosis in HBV-DeCi patients, and more attention should be paid to anemia in routine clinical assessments of liver cirrhosis.
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
January 2019,
BioMed research international,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
January 2016,
Gastroenterology research and practice,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
January 2017,
Medicine,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
January 2019,
Clinical laboratory,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
December 2019,
Medicine,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
September 2018,
Annals of clinical and laboratory science,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
April 2023,
Clinical laboratory,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
December 2018,
Clinical and molecular hepatology,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
February 2003,
Seminars in liver disease,
Ming Cai, and
Na Yang, and
Sha Lin, and
Bo Ye, and
Hui Chen, and
Wei-Lin Mao
August 2013,
Clinics in liver disease,
